Is a complete BNGO research report available?

No complete published report is available for Bionano Genomics, Inc. (BNGO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Bionano Genomics, Inc. (BNGO)

NASDAQ: BNGO · USD

$1.20

-0.02 (-1.6%)· Recorded snapshot

Market cap	14.1M
Revenue (ttm)	30.2M
Net income (ttm)	-32.2M
EPS (ttm)	-$3.37
Shares out	11.8M
Volume	110,131
Beta	1.66

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 30.2M
Net income (ttm): -32.2M
EPS (ttm): -$3.37
Market cap: 14.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001411690
Company name	Bionano Genomics, Inc.
Country	United States
Country code	US
CUSIP number	09075F404
Earnings date	2026-11-10
Earnings time	amc
Employees	97
Employees change	-3
Employees growth	-3%
Enterprise value	$10.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Medical Instruments & Supplies
IPO date	2018-08-21
Is primary listing	Yes
Is SPAC	No
ISIN number	US09075F4046
Last 10-K release date	2026-03-23
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2025-01-27
Last stock split type	Reverse
Market cap	$14.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$1.20
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	BNGO
U.S. state	California
Website	https://bionano.com

Metric

Value

Amount currency

USD

CIK code

0001411690

Company name

Bionano Genomics, Inc.

Country

United States

Country code

CUSIP number

09075F404

Earnings date

2026-11-10

Earnings time

amc

Employees

Employees change

-3

Employees growth

-3%

Enterprise value

$10.9M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2003

Industry

Medical Instruments & Supplies

IPO date

2018-08-21

Is primary listing

Yes

Is SPAC

ISIN number

US09075F4046

Last 10-K release date

2026-03-23

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2025-01-27

Last stock split type

Reverse

Market cap

$14.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Price

$1.20

Price currency

USD

Sector

Healthcare

SIC code

3826

Stock price date

2026-10-28

Symbol

BNGO

U.S. state

California

Website

https://bionano.com

Metric	Value
Earnings yield	-280.89%
EV/Sales	0.37x
FCF / EV yield	-182.66%
FCF yield	-141.95%
Forward EV/Sales	0.31x
Forward P/S	0.4x
Industry forward P/E	22.69x
Industry P/E	75.18x
P/B ratio	0.45x
P/S ratio	0.48x
Price / tangible book value	0.48x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-280.89%

EV/Sales

0.37x

FCF / EV yield

-182.66%

FCF yield

-141.95%

Forward EV/Sales

0.31x

Forward P/S

0.4x

Industry forward P/E

22.69x

Industry P/E

75.18x

P/B ratio

0.45x

P/S ratio

0.48x

Price / tangible book value

0.48x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
EBIT margin	-106.68%
EBITDA margin	-75.12%
Gross margin	47.5%
Operating margin	-106.68%
Pretax margin	-106.37%
Profit margin	-106.58%
Profit per employee	$-331,577
Revenue per employee	$311,093
ROA	-32.56%
ROA (5Y)	-28.72%
ROCE	-85.73%
ROE	-83.56%
ROE (5Y)	-91.04%
ROIC	-38.97%
SBC / revenue	11.62%
Tax / revenue	0.22%

Metric

Value

EBIT margin

-106.68%

EBITDA margin

-75.12%

Gross margin

47.5%

Operating margin

-106.68%

Pretax margin

-106.37%

Profit margin

-106.58%

Profit per employee

$-331,577

Revenue per employee

$311,093

ROA

-32.56%

ROA (5Y)

-28.72%

ROCE

-85.73%

ROE

-83.56%

ROE (5Y)

-91.04%

ROIC

-38.97%

SBC / revenue

11.62%

Tax / revenue

0.22%

Metric	Value
EPS growth quarters	11
EPS growth years	2
Gross profit growth	932.78%
Gross profit growth (Q)	24.07%
Gross profit growth 3Y	21.51%
Gross profit growth 5Y	26.67%
Net income growth years	2
Revenue growth	10.03%
Revenue growth (Q)	21.36%
Revenue growth (QoQ)	22.19%
Revenue growth 3Y	-1.43%
Revenue growth 5Y	17.97%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

932.78%

Gross profit growth (Q)

24.07%

Gross profit growth 3Y

21.51%

Gross profit growth 5Y

26.67%

Net income growth years

Revenue growth

10.03%

Revenue growth (Q)

21.36%

Revenue growth (QoQ)

22.19%

Revenue growth 3Y

-1.43%

Revenue growth 5Y

17.97%

Revenue growth quarters

Revenue growth years

Metric	Value
Depreciation and amortization	$9.5M
EBIT	$-32.2M
EBITDA	$-22.7M
EPS	$-3.37
FCF per share	$-1.74
Financing cash flow	$2.6M
Free cash flow	$-20.5M
Free cash flow minus SBC	$-24M
Gross profit	$14.3M
Income taxes	$66,000
Investing cash flow	$18.5M
Net borrowing	$-12.2M
Net cash flow	$669,000
Net income	$-32.2M
Operating cash flow minus SBC	$-24M
Operating income	$-32.2M
Revenue	$30.2M
Stock-based compensation	$3.5M

Metric

Value

Depreciation and amortization

$9.5M

EBIT

$-32.2M

EBITDA

$-22.7M

EPS

$-3.37

FCF per share

$-1.74

Financing cash flow

$2.6M

Free cash flow

$-20.5M

Free cash flow minus SBC

$-24M

Gross profit

$14.3M

Income taxes

$66,000

Investing cash flow

$18.5M

Net borrowing

$-12.2M

Net cash flow

$669,000

Net income

$-32.2M

Operating cash flow minus SBC

$-24M

Operating income

$-32.2M

Revenue

$30.2M

Stock-based compensation

$3.5M

Metric	Value
Altman Z-Score	-22.31
Book value per share	$2.68
Debt / equity	0.21
Interest coverage	-114.16
Long-term assets	$22.7M
Long-term liabilities	$5.9M
Net cash (debt)	$3.2M
Net cash / market cap	22.28%
Net debt / equity	-0.1
Piotroski F-Score	4
Property, plant and equipment	$18.9M
Shareholders' equity	$31.6M
Tangible book value	$29.9M
Tangible book value per share	$2.54
Total assets	$47.6M
Total cash	$9.9M
Total debt	$6.7M
Total liabilities	$16M
WACC	10.18%

Metric

Value

Altman Z-Score

-22.31

Book value per share

$2.68

Debt / equity

0.21

Interest coverage

-114.16

Long-term assets

$22.7M

Long-term liabilities

$5.9M

Net cash (debt)

$3.2M

Net cash / market cap

22.28%

Net debt / equity

-0.1

Piotroski F-Score

Property, plant and equipment

$18.9M

Shareholders' equity

$31.6M

Tangible book value

$29.9M

Tangible book value per share

$2.54

Total assets

$47.6M

Total cash

$9.9M

Total debt

$6.7M

Total liabilities

$16M

WACC

10.18%

Metric	Value
Asset turnover	0.49
Current assets	$24.9M
Current liabilities	$10M
Current ratio	2.48
Inventory turnover	2.29
Net working capital	$5.8M
Quick ratio	1.42
Working capital	$14.8M
Working capital turnover	1.81

Metric

Value

Asset turnover

0.49

Current assets

$24.9M

Current liabilities

$10M

Current ratio

2.48

Inventory turnover

2.29

Net working capital

$5.8M

Quick ratio

1.42

Working capital

$14.8M

Working capital turnover

1.81

Metric	Value
Buyback yield / dilution	-314.06%
Dividend yield	0%
Shareholder yield	-314.06%

Metric

Value

Buyback yield / dilution

-314.06%

Dividend yield

Shareholder yield

-314.06%

Metric	Value
150-day SMA	$1.25
1D price change	-1.64%
1M price change	-27.71%
1M total return	-27.71%
1W price change	-4%
1W total return	-4%
1Y price change	-37.17%
1Y return CAGR	-37.19%
1Y total return	-37.17%
20-day SMA	$1.33
200-day SMA	$1.25
3M price change	11.11%
3M total return	11.11%
3Y price change	-98.41%
3Y return CAGR	-74.86%
3Y total return	-98.41%
50-day SMA	$1.38
50-day SMA vs 200-day SMA	50over200
52-week high	$2.23
52-week high date	2026-09-15
52-week low	$1.00
52-week low date	2026-07-31
5Y price change	-99.96%
5Y return CAGR	-79.13%
5Y total return	-99.96%
6M price change	-2.44%
6M total return	-2.44%
All-time high	$9,413.98
All-time high date	2021-02-16
All-time low	$1.00
All-time low date	2026-07-31
Average true range (ATR)	$0.09
Average volume	220.1K
Beta (1Y)	1.39
Beta (2Y)	1.35
Beta (5Y)	1.66
Change from 52-week high	-46.19%
Change from 52-week low	20%
Change from all-time high	-99.99%
Change from all-time low	20%
Change from open	-2.44%
Day's gap	0.82%
Dollar volume	$132,157
High price	$1.25
Low price	$1.20
Monthly RSI	33.36
Open price	$1.23
Position in 52-week range	0%
Premarket change	0.82%
Premarket close	$1.22
Premarket price	$1.23
Previous close	$1.22
Price vs 150-day SMA	-3.69%
Price vs 20-day SMA	-9.77%
Price vs 200-day SMA	-3.69%
Price vs 50-day SMA	-12.79%
Relative volume	0.5
RSI	38.14
Sharpe ratio	-0.51
Sharpe ratio (3Y)	-1.18
Sharpe ratio (5Y)	-1.34
Sortino ratio	-0.67
Sortino ratio (3Y)	-1.61
Sortino ratio (5Y)	-1.83
Volume	110.1K
Weekly RSI	44.31
YTD price change	-21.57%
YTD total return	-21.57%

Metric

Value

150-day SMA

$1.25

1D price change

-1.64%

1M price change

-27.71%

1M total return

-27.71%

1W price change

-4%

1W total return

-4%

1Y price change

-37.17%

1Y return CAGR

-37.19%

1Y total return

-37.17%

20-day SMA

$1.33

200-day SMA

$1.25

3M price change

11.11%

3M total return

11.11%

3Y price change

-98.41%

3Y return CAGR

-74.86%

3Y total return

-98.41%

50-day SMA

$1.38

50-day SMA vs 200-day SMA

50over200

52-week high

$2.23

52-week high date

2026-09-15

52-week low

$1.00

52-week low date

2026-07-31

5Y price change

-99.96%

5Y return CAGR

-79.13%

5Y total return

-99.96%

6M price change

-2.44%

6M total return

-2.44%

All-time high

$9,413.98

All-time high date

2021-02-16

All-time low

$1.00

All-time low date

2026-07-31

Average true range (ATR)

$0.09

Average volume

220.1K

Beta (1Y)

1.39

Beta (2Y)

1.35

Beta (5Y)

1.66

Change from 52-week high

-46.19%

Change from 52-week low

20%

Change from all-time high

-99.99%

Change from all-time low

20%

Change from open

-2.44%

Day's gap

0.82%

Dollar volume

$132,157

High price

$1.25

Low price

$1.20

Monthly RSI

33.36

Open price

$1.23

Position in 52-week range

Premarket change

0.82%

Premarket close

$1.22

Premarket price

$1.23

Previous close

$1.22

Price vs 150-day SMA

-3.69%

Price vs 20-day SMA

-9.77%

Price vs 200-day SMA

-3.69%

Price vs 50-day SMA

-12.79%

Relative volume

0.5

RSI

38.14

Sharpe ratio

-0.51

Sharpe ratio (3Y)

-1.18

Sharpe ratio (5Y)

-1.34

Sortino ratio

-0.67

Sortino ratio (3Y)

-1.61

Sortino ratio (5Y)

-1.83

Volume

110.1K

Weekly RSI

44.31

YTD price change

-21.57%

YTD total return

-21.57%

Metric	Value
Float	10.6M
Float percentage	90.32%
Shares change (QoQ)	5.16%
Shares change (YoY)	314.06%
Shares held by insiders	0.09%
Shares held by institutions	20.87%
Shares outstanding	11.8M
Short % of float	12.79%
Short % of shares	11.55%
Short ratio	0.9 days

Metric

Value

Float

10.6M

Float percentage

90.32%

Shares change (QoQ)

5.16%

Shares change (YoY)

314.06%

Shares held by insiders

0.09%

Shares held by institutions

20.87%

Shares outstanding

11.8M

Short % of float

12.79%

Short % of shares

11.55%

Short ratio

0.9 days

Bionano Genomics, Inc. (BNGO)

Price

Financial snapshot

Fair-value bridge

Latest news · BNGO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNGO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BNGO

Frequently asked questions